Abstract
Alzheimer disease (AD) is an age-related neurodegenerative disorder, characterized histopathologically by the presence of senile plaques (SP), neurofibrillary tangles and synapse loss in selected brain regions. Positron emission tomography (PET) studies of glucose metabolism revealed decreased energetics in brain of subjects with AD and arguably its earliest form, mild cognitive impairment (MCI), and this decrease correlated with brain structural studies using MRI. The main component of senile plaques is amyloid beta-peptide (Aβ), a 40–42 amino acid peptide that as oligomers is capable of inducing oxidative stress under both in vitro and in vivo conditions and is neurotoxic. In the mitochondria isolated from AD brain, Aβ oligomers that correlated with the reported increased oxidative stress markers in AD have been reported. The markers of oxidative stress have been localized in the brain regions of AD and MCI that show pathological hallmarks of this disease, suggesting the possible role of Aβ in the initiation of the free-radical mediated process and consequently to the build up oxidative stress and AD pathogenesis. Using redox proteomics our laboratory found a number of oxidatively modified brain proteins that are directly in or are associated with the mitochondrial proteome, consistent with a possible involvement of the mitochondrial targeted oxidatively modified proteins in AD progression or pathogenesis. The precise mechanistic link between mitochondrial oxidative damage and role of oligomeric Aβ has not been explicated. In this review, we discuss the role of the oxidation of mitochondria-relevant brain proteins to the pathogenesis and progression of AD.
Similar content being viewed by others
References
Aksenov M, Aksenova M, Butterfield DA, Markesbery WR (2000) J Neurochem 74:2520–2527
Aleardi AM, Benard G, Augereau O, Malgat M, Talbot JC, Mazat JP, Letellier T, Dachary-Prigent J, Solaini GC, Rossignol R (2005) J Bioenerg Biomembr 37:207–225
Atamna H, Frey WH 2nd (2007) Mitochondrion 7:297–310
Bader Lange ML, Cenini G, Piroddi M, Abdul HM, Sultana R, Galli F, Memo M, Butterfield DA (2008) Neurobiol Dis 29:456–464
Bosetti F, Brizzi F, Barogi S, Mancuso M, Siciliano G, Tendi EA, Murri L, Rapoport SI, Solaini G (2002) Neurobiol Aging 23:371–376
Boyd-Kimball D, Mohmmad Abdul H, Reed T, Sultana R, Butterfield DA (2004) Chem Res Toxicol 17:1743–1749
Boyd-Kimball D, Sultana R, Mohmmad-Abdul H, Butterfield DA (2005) Peptides 26:665–673
Bubber P, Haroutunian V, Fisch G, Blass JP, Gibson GE (2005) Ann Neurol 57:695–703
Butterfield DA, Boyd-Kimball D (2005) Biochim Biophys Acta 1703:149–156
Butterfield DA, Kanski J (2002) Peptides 23:1299–1309
Butterfield DA, Lauderback CM (2002) Free Radic Biol Med 32:1050–1060
Butterfield DA, Stadtman ER (1997) Adv Cell Aging Gerontol 2:161–191
Butterfield DA, Drake J, Pocernich C, Castegna A (2001) Trends Mol Med 7:548–554
Butterfield DA, Poon HF, St Clair D, Keller JN, Pierce WM, Klein JB, Markesbery WR (2006a) Neurobiol Dis 22:223–232
Butterfield DA, Reed T, Perluigi M, De Marco C, Coccia R, Cini C, Sultana R (2006b) Neurosci Lett 397:170–173
Butterfield DA, Reed T, Newman SF, Sultana R (2007a) Free Radic Biol Med 43:658–677
Butterfield DA, Reed TT, Perluigi M, De Marco C, Coccia R, Keller JN, Markesbery WR, Sultana R (2007b) Brain Res 1148:243–248
Carre M, Andre N, Carles G, Borghi H, Brichese L, Briand C, Braguer D (2002) J Biol Chem 277:33664–33669
Casley CS, Canevari L, Land JM, Clark JB, Sharpe MA (2002) J Neurochem 80:91–100
Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, Xu HW, Stern D, McKhann G, Yan SD (2005) Faseb J 19:2040–2041
Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA (2002) Free Radic Biol Med 33:562–571
Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, Butterfield DA (2003) J Neurochem 85:1394–1401
Chertkow H, Bergman H, Schipper HM, Gauthier S, Bouchard R, Fontaine S, Clarfield AM (2001) Can J Neurol Sci 28(Suppl 1):S28–S41
Clementi ME, Pezzotti M, Orsini F, Sampaolese B, Mezzogori D, Grassi C, Giardina B, Misiti F (2006) Biochem Biophys Res Commun 342:206–213
Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, McCord JM, Harman D (1987) Ann Intern Med 107:526–545
Crouch PJ, Barnham KJ, Duce JA, Blake RE, Masters CL, Trounce IA (2006) J Neurochem 99:226–236
Crouch PJ, Cimdins K, Duce JA, Bush AI, Trounce IA (2007) Rejuvenation Res 10:349–357
Crouch PJ, Harding SM, White AR, Camakaris J, Bush AI, Masters CL (2008) Int J Biochem Cell Biol 40:181–198
Cruts M, van Duijn CM, Backhovens H, Van den Broeck M, Wehnert A, Serneels S, Sherrington R, Hutton M, Hardy J, St George-Hyslop PH, Hofman A, Van Broeckhoven C (1998) Hum Mol Genet 7:43–51
Csordas G, Hajnoczky G (2003) J Biol Chem 278:42273–42282
Dimou E, Booij J, Rodrigues M, Prosch H, Attems J, Knoll P, Zajicek B, Dudczak R, Mostbeck G, Kuntner C, Langer O, Bruecke T, Mirzaei S (2009) Curr Alzheimer Res 6:312–319
Ding Q, Markesbery WR, Cecarini V, Keller JN (2006) Neurochem Res 31:705–710
Drake J, Link CD, Butterfield DA (2003) Neurobiol Aging 24:415–420
Etoh S, Matsui H, Tokuda M, Itano T, Nakamura M, Hatase O (1990) Biochem Int 20:599–606
Gabbita SP, Lovell MA, Markesbery WR (1998) J Neurochem 71:2034–2040
Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L et al (1991) Nature 349:704–706
Good PF, Werner P, Hsu A, Olanow CW, Perl DP (1996) Am J Pathol 149:21–28
Hardy J, Selkoe DJ (2002) Science 297:353–356
Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita SP, Wu JF, Carney JM et al (1995) J Neurochem 65:2146–2156
Kanski J, Aksenova M, Schoneich C, Butterfield DA (2002) Free Radic Biol Med 32:1205–1211
Katzman R, Saitoh T (1991) Faseb J 5:278–286
Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbery WR (2005) Neurology 64:1152–1156
Lambert JC, Mann DM, Harris JM, Chartier-Harlin MC, Cumming A, Coates J, Lemmon H, StClair D, Iwatsubo T, Lendon C (2001) J Med Genet 38:353–355
Lauderback CM, Hackett JM, Huang FF, Keller JN, Szweda LI, Markesbery WR, Butterfield DA (2001a) J Neurochem 78:413–416
Lauderback CM, Hackett JM, Keller JN, Varadarajan S, Szweda L, Kindy M, Markesbery WR, Butterfield DA (2001b) Biochemistry 40:2548–2554
Lemire J, Mailloux RJ, Appanna VD (2008) PLoS One 3:e1550
Lorenzo HK, Susin SA, Penninger J, Kroemer G (1999) Cell Death Differ 6:516–524
Lovell MA, Markesbery WR (2001) Arch Neurol 58:392–396
Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH (2006) Hum Mol Genet 15:1437–1449
Mangia S, Simpson IA, Vannucci SJ, Carruthers A (2009) J Neurochem 109(Suppl 1):55–62
Markesbery WR (1997) Free Radic Biol Med 23:134–147
Markesbery WR, Kryscio RJ, Lovell MA, Morrow JD (2005) Ann Neurol 58:730–735
Mattson MP, Liu D (2002) Neuromolecular Med 2:215–231
Mecocci P, MacGarvey U, Beal MF (1994) Ann Neurol 36:747–751
Migliore L, Fontana I, Trippi F, Colognato R, Coppede F, Tognoni G, Nucciarone B, Siciliano G (2005) Neurobiol Aging 26:567–573
Montine TJ, Neely MD, Quinn JF, Beal MF, Markesbery WR, Roberts LJ, Morrow JD (2002) Free Radic Biol Med 33:620–626
Morris JC, Cummings J (2005) J Alzheimers Dis 7:235–239
Murray IV, Sindoni ME, Axelsen PH (2005) Biochemistry 44:12606–12613
Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, Smith MA (1999) J Neurosci 19:1959–1964
Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA (2001) J Neuropathol Exp Neurol 60:759–767
Oda T, Wals P, Osterburg HH, Johnson SA, Pasinetti GM, Morgan TE, Rozovsky I, Stine WB, Snyder SW, Holzman TF et al (1995) Exp Neurol 136:22–31
Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Arch Neurol 56:303–308
Reed T, Perluigi M, Sultana R, Pierce WM, Klein JB, Turner DM, Coccia R, Markesbery WR, Butterfield DA (2008) Neurobiol Dis 30:107–120
Saido TC (2003) Aβ Metabolism and Alzheimer’s Disease. Landes Bioscience, Georgetown, TX
Salmon DP, Thomas RG, Pay MM, Booth A, Hofstetter CR, Thal LJ, Katzman R (2002) Neurology 59:1022–1028
Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA (1997) J Neurochem 68:2092–2097
Schagger H, Ohm TG (1995) Eur J Biochem 227:916–921
Schmidt C, Lepsverdize E, Chi SL, Das AM, Pizzo SV, Dityatev A, Schachner M (2008) Mol Psychiatry 13:953–969
Shoshan-Barmatz V, Israelson A, Brdiczka D, Sheu SS (2006) Curr Pharm Des 12:2249–2270
Sims NR (1990) Ann Neurol 27:691–693
Smith MA, Sayre LM, Monnier VM, Perry G (1995) Trends Neurosci 18:172–176
Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G (1997) J Neurosci 17:2653–2657
Subramaniam R, Roediger F, Jordan B, Mattson MP, Keller JN, Waeg G, Butterfield DA (1997) J Neurochem 69:1161–1169
Sultana R, Butterfield DA (2004) Neurochem Res 29:2215–2220
Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, Merchant M, Markesbery WR, Butterfield DA (2006a) Neurobiol Aging 27:1564–1576
Sultana R, Poon HF, Cai J, Pierce WM, Merchant M, Klein JB, Markesbery WR, Butterfield DA (2006b) Neurobiol Dis 22:76–87
Susin SA, Lorenzo HK, Zamzami N, Marzo I, Brenner C, Larochette N, Prevost MC, Alzari PM, Kroemer G (1999) J Exp Med 189:381–394
Tarze A, Deniaud A, Le Bras M, Maillier E, Molle D, Larochette N, Zamzami N, Jan G, Kroemer G, Brenner C (2007) Oncogene 26:2606–2620
Varadarajan S, Kanski J, Aksenova M, Lauderback C, Butterfield DA (2001) J Am Chem Soc 123:5625–5631
Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A (1994) Proc Natl Acad Sci U S A 91:4766–4770
Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, Benedek GB, Selkoe DJ, Teplow DB (1999) J Biol Chem 274:25945–25952
Wang J, Markesbery WR, Lovell MA (2006) J Neurochem 96:825–832
Weeber EJ, Levy M, Sampson MJ, Anflous K, Armstrong DL, Brown SE, Sweatt JD, Craigen WJ (2002) J Biol Chem 277:18891–18897
Williams TI, Lynn BC, Markesbery WR, Lovell MA (2006) Neurobiol Aging 27:1094–1099
Zhang YW, Xu H (2007) Curr Mol Med 7:687–696
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sultana, R., Butterfield, D.A. Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment. J Bioenerg Biomembr 41, 441–446 (2009). https://doi.org/10.1007/s10863-009-9241-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-009-9241-7